Venous thromboembolism
- Watch Video(FLV)
Value through Innovation17 January 2013
Venous Thromboembolism (VTE) News and Information
This section includes information and resources about venous Thromboembolism (VTE) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Venous Thromoboembolism (VTE) Press Releases
| 09.06.2008 |
Boehringer Ingelheim announces first positive health technology assessments for novel oral anticoagulant Pradaxa® (dabigatran etexilate) - For medical media, outside the US only |
|---|---|
| 27.03.2008 |
Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission - For medical media, outside the US only |
| 25.01.2008 |
European Medicines Agency recommends approval of novel oral anticoagulant, dabigatran etexilate (Pradaxa®) - For medical media, outside the US only |
VTE Related News Room
VTE Related Documents
- Backgrounder: Dabigatran etexilate - 2010 - PDF (795 KB)
- Backgrounder: RE-COVER Study - 2010 - PDF (561 KB)
- Backgrounder: VTE indication - 2010 - PDF (3 MB)
- Fact sheet: Dabigatran Etexilate - 2008 - PDF (63 KB)
- Fact sheet: Dabigatran Etexilate - A Breakthrough in Anticoagulation - 2008 - PDF (55 KB)
- Backgrounder: Dabigatran Etexilate - A brief history - 2008 - PDF (35 KB)
- Backgrounder: Venous Thromboembolism (VTE) - 2008 - PDF (51 KB)
- Glossary: Thromboembolic Diseases - 2008 - PDF (42 KB)
VTE Video Gallery
VTE Image Gallery
-
Injection
Injection to prevent thrombosis after a knee replacement surgery.
-
Prevention I
Dabigatran etexilate preventing venous thromboic events (VTE).
-
Prevention II
Dabigatran etexilate preventing venous thromboic events (VTE).
